LD-2 disclosure · 3rd Quarter - Termination
ALEXION PHARMACEUTICALS, INC.
via ALEXION PHARMACEUTICALS, INC.
Client
- Name
- ALEXION PHARMACEUTICALS, INC.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- ALEXION PHARMACEUTICALS, INC.
- Description
- Global biopharmaceutical company
- Location
- Boston, Massachusetts, United States of America
Lobbying activities
4 issuesTaxation/Internal Revenue Code
H.R. 5376, Build Back Better Act Issues related to the Orphan Drug Tax Credit
LobbyistsKATIE JONES
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform
LobbyistsKATIE JONES
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 482/S. 350, Newborn Screening Saves Lives Reauthorization Act of 2021 H.R. 1730/S. 670, Speeding Therapy Access Today Act of 2021 Cures 2.0 Discussion Draft; Diverse and Equitable Participation in Clinical Trials Act Discussion Draft General issues related to orphan disease drugs; FDA modernization policy issues; Reauthorization of newborn screening programs; Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients; general issues related to health equity in rare disease; general issues related to health equity in rare disease and clinical trials; general issues related to diagnostics for patients with rare diseases
LobbyistsKATIE JONES